Sign in
CompletedPhase 1

Study on the investigational drug SAN711, placebo-controlled, administered to healthy adults and elderly subjects at multiple ascending oral doses to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics of SAN711 and its interaction with food

Key facts

Who runs it
Saniona A/S
Where
Italy1 site in 1 countryChoose a country to see its sites
Status
Completed
Phase
Phase 1
People taking part
50 people enrolled
Started
12 Feb 2025
Ended
15 Nov 2025
Type of study
Interventional
Record updated
8 July 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Can take part

Where is this trial?

It has sites in one country. Choose a country to see its sites.

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Record updated
8 July 2025